Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Aug 10;15(8):e43307.
doi: 10.7759/cureus.43307. eCollection 2023 Aug.

Minocycline-Induced Ocular Ochronosis

Affiliations
Case Reports

Minocycline-Induced Ocular Ochronosis

Carla Baaklini et al. Cureus. .

Abstract

We report a case of minocycline-induced ocular ochronosis with scleral, retinal, and cutaneous manifestations. A 65-year-old male who had taken minocycline for four years to treat hidradenitis suppurativa, an inflammatory skin condition affecting the apocrine sweat glands and hair follicles, presented for evaluation of discoloration of bilateral sclera, nail beds, and gingiva. Ophthalmic evaluation revealed intact visual acuity, diffuse blue-gray hyperpigmentation of the sclera, more pronounced overlying insertions of the horizontal muscles, without any scleral thinning. Macular optical coherence tomography and fundus exam revealed a blue hue to the underlying choroid with dark deposits in the retinal pigment epithelium. Despite drug discontinuation, after six years the discoloration persisted. Management was directed towards patient tolerability.

Keywords: hyperpigmentation; minocycline; ocular ochronosis; retinal pigment epithelium deposits; scleral hyperpigmentation.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Blue discoloration of sclera with prominence in palpebral aperture. There is an area 5.5 mm posterior to the limbus where the scleral coloration becomes more prominent.
Figure 2
Figure 2. Blue discoloration of oral mucosa (A) and fingernails (B).
Figure 3
Figure 3. A: Anterior segment optical coherent tomography of the temporal left eye showing lack of scleral thinning. B: Anterior segment optical coherent tomography showing lack of scleral thinning nasally.
Figure 4
Figure 4. A: Right eye fundus photography showing bluish appearance to macula. B: Pigmented retinal pigment epithelium deposits seen on optical coherence tomography.

References

    1. UpToDate. Waltham: UpToDate; [ Oct; 2022 ]. 2023. Minocycline (systemic): drug information.
    1. Blue skin, nail, and scleral pigmentation associated with minocycline. Ricardo JW, Shah K, Minkis K, Lipner SR. Case Rep Dermatol. 2022;14:239–242. - PMC - PubMed
    1. Minocycline-induced blue sclera and skin hyperpigmentation. Law S. BMJ Case Rep. 2021;14 - PMC - PubMed
    1. Minocycline-induced scleral pigmentation. Al Hussein Al Awamlh S, Taubenslag KJ, Gangaputra S. Am J Ophthalmol Case Rep. 2022;26:101386. - PMC - PubMed
    1. Minocycline-induced scleral pigmentation. Fraunfelder FT, Randall JA. Ophthalmology. 1997;104:936–938. - PubMed

Publication types

LinkOut - more resources